This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McMullen, J. R.
Right arrow Articles by Izumo, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McMullen, J. R.
Right arrow Articles by Izumo, S.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, July 2004, p. 6231-6240, Vol. 24, No. 14
0270-7306/04/$08.00+0     DOI: 10.1128/MCB.24.14.6231-6240.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Deletion of Ribosomal S6 Kinases Does Not Attenuate Pathological, Physiological, or Insulin-Like Growth Factor 1 Receptor-Phosphoinositide 3-Kinase-Induced Cardiac Hypertrophy

Julie R. McMullen,1* Tetsuo Shioi,1 Li Zhang,1 Oleg Tarnavski,1 Megan C. Sherwood,2 Adam L. Dorfman,2 Sarah Longnus,1 Mario Pende,3 Kathleen A. Martin,4 John Blenis,4 George Thomas,3 and Seigo Izumo1

Beth Israel Deaconess Medical Center,1 Department of Cell Biology, Harvard Medical School,4 Department of Cardiology, Boston Children's Hospital, Boston, Massachusetts,2 Friedrich Miescher Institute for Biomedical Research, Basel, Switzerland3

Received 12 April 2004/ Returned for modification 23 April 2004/ Accepted 28 April 2004

Ribosomal S6 kinases (S6Ks) have been depicted as critical effectors downstream of growth factor pathways, which play an important role in the regulation of protein synthesis by phosphorylating the ribosomal protein, S6. The goal of this study was to determine whether S6Ks regulate heart size, are critical for the induction of cardiac hypertrophy in response to a pathological or physiological stimulus, and whether S6Ks are critical downstream effectors of the insulin-like growth factor 1 (IGF1)-phosphoinositide 3-kinase (PI3K) pathway. For this purpose, we generated and characterized cardiac-specific S6K1 and S6K2 transgenic mice and subjected S6K1–/–, S6K2–/–, and S6K1–/– S6K2–/– mice to a pathological stress (aortic banding) or a physiological stress (exercise training). To determine the genetic relationship between S6Ks and the IGF1-PI3K pathway, S6K transgenic and knockout mice were crossed with cardiac-specific transgenic mice overexpressing the IGF1 receptor (IGF1R) or PI3K mutants. Here we show that overexpression of S6K1 induced a modest degree of hypertrophy, whereas overexpression of S6K2 resulted in no obvious cardiac phenotype. Unexpectedly, deletion of S6K1 and S6K2 had no impact on the development of pathological, physiological, or IGF1R-PI3K-induced cardiac hypertrophy. These studies suggest that S6Ks alone are not essential for the development of cardiac hypertrophy.

* Corresponding author. Mailing address: Beth Israel Deaconess Medical Center, Cardiovascular Division, 330 Brookline Ave., SL-408, Boston, MA 02215. Phone: (617) 667-4863. Fax: (617) 975-5268. E-mail: jmcmulle{at}bidmc.harvard.edu.

Molecular and Cellular Biology, July 2004, p. 6231-6240, Vol. 24, No. 14
0022-538X/04/$08.00+0     DOI: 10.1128/MCB.24.14.6231-6240.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Chen, J.-K., Chen, J., Thomas, G., Kozma, S. C., Harris, R. C. (2009). S6 kinase 1 knockout inhibits uninephrectomy- or diabetes-induced renal hypertrophy. Am. J. Physiol. Renal Physiol. 297: F585-F593 [Abstract] [Full Text]  
  • Braz, J. C., Gill, R. M., Corbly, A. K., Jones, B. D., Jin, N., Vlahos, C. J., Wu, Q., Shen, W. (2009). Selective activation of PI3K{alpha}/Akt/GSK-3{beta} signalling and cardiac compensatory hypertrophy during recovery from heart failure. Eur J Heart Fail 11: 739-748 [Abstract] [Full Text]  
  • Oudit, G. Y., Penninger, J. M. (2009). Cardiac regulation by phosphoinositide 3-kinases and PTEN. Cardiovasc Res 82: 250-260 [Abstract] [Full Text]  
  • Kurabe, N., Arai, S., Nishijima, A., Kubota, N., Suizu, F., Mori, M., Kurokawa, J., Kondo-Miyazaki, M., Ide, T., Murakami, K., Miyake, K., Ueki, K., Koga, H., Yatomi, Y., Tashiro, F., Noguchi, M., Kadowaki, T., Miyazaki, T. (2009). The Death Effector Domain-containing DEDD Supports S6K1 Activity via Preventing Cdk1-dependent Inhibitory Phosphorylation. J. Biol. Chem. 284: 5050-5055 [Abstract] [Full Text]  
  • Huang, B. P. H., Wang, Y., Wang, X., Wang, Z., Proud, C. G. (2009). Blocking eukaryotic initiation factor 4F complex formation does not inhibit the mTORC1-dependent activation of protein synthesis in cardiomyocytes. Am. J. Physiol. Heart Circ. Physiol. 296: H505-H514 [Abstract] [Full Text]  
  • Xu, X., Fassett, J., Hu, X., Zhu, G., Lu, Z., Li, Y., Schnermann, J., Bache, R. J., Chen, Y. (2008). Ecto-5'-Nucleotidase Deficiency Exacerbates Pressure-Overload-Induced Left Ventricular Hypertrophy and Dysfunction. Hypertension 51: 1557-1564 [Abstract] [Full Text]  
  • Shen, W.-H., Chen, Z., Shi, S., Chen, H., Zhu, W., Penner, A., Bu, G., Li, W., Boyle, D. W., Rubart, M., Field, L. J., Abraham, R., Liechty, E. A., Shou, W. (2008). Cardiac Restricted Overexpression of Kinase-dead Mammalian Target of Rapamycin (mTOR) Mutant Impairs the mTOR-mediated Signaling and Cardiac Function. J. Biol. Chem. 283: 13842-13849 [Abstract] [Full Text]  
  • Shiojima, I., Walsh, K. (2006). Regulation of cardiac growth and coronary angiogenesis by the Akt/PKB signaling pathway. Genes Dev. 20: 3347-3365 [Abstract] [Full Text]  
  • DeBosch, B., Sambandam, N., Weinheimer, C., Courtois, M., Muslin, A. J. (2006). Akt2 Regulates Cardiac Metabolism and Cardiomyocyte Survival. J. Biol. Chem. 281: 32841-32851 [Abstract] [Full Text]  
  • Wang, X., Proud, C. G. (2006). The mTOR Pathway in the Control of Protein Synthesis.. Physiology 21: 362-369 [Abstract] [Full Text]  
  • Goldsmith, A. M., Bentley, J. K., Zhou, L., Jia, Y., Bitar, K. N., Fingar, D. C., Hershenson, M. B. (2006). Transforming Growth Factor-beta Induces Airway Smooth Muscle Hypertrophy. Am. J. Respir. Cell Mol. Bio. 34: 247-254 [Abstract] [Full Text]  
  • Luo, J., McMullen, J. R., Sobkiw, C. L., Zhang, L., Dorfman, A. L., Sherwood, M. C., Logsdon, M. N., Horner, J. W., DePinho, R. A., Izumo, S., Cantley, L. C. (2005). Class IA Phosphoinositide 3-Kinase Regulates Heart Size and Physiological Cardiac Hypertrophy. Mol. Cell. Biol. 25: 9491-9502 [Abstract] [Full Text]  
  • Ha, T., Li, Y., Hua, F., Ma, J., Gao, X., Kelley, J., Zhao, A., Haddad, G. E., Williams, D. L., William Browder, I., Kao, R. L., Li, C. (2005). Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload. Cardiovasc Res 68: 224-234 [Abstract] [Full Text]  
  • Sano, M., Schneider, M. D. (2004). Cyclin-Dependent Kinase-9: An RNAPII Kinase at the Nexus of Cardiac Growth and Death Cascades. Circ. Res. 95: 867-876 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»